Procaterol exhibited an antiproliferative effect in luminal (MCF-7) and triple-negative (MDA-MB-231) BC cell lines at micromolar concentrations, comparable to those of the reference ERβ agonist (Diarylpropionitrile, DPN). Here, ESR2 is linked to breast cancer.